NOVT

Novanta Inc.

$123.71

-15.26%
SectorTechnologyIndustryScientific & Technical InstrumentsCountryUnited States

Novanta Inc., together with its subsidiaries, provides precision medicine, precision manufacturing, medical solutions, robotics and automation solutions, and advanced surgery solutions in the United States and internationally. The company operates Automation Enabling Technologies and Medical Solutions segments. The Precision Medicine and Manufacturing segment designs, manufactures, and markets laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles. This segment serves advanced industrial processes, advanced industrial and medical robotics, other medical and life science automation applications, and medical laser procedures, such as ophthalmology applications.

Source: Yahoo Finance
AI summary

Price & performance

1M-12.4%
3M-24.5%
YTD+11.3%
1Y+19.0%
52-week range—
Beta1.74
Full chart and returns against a benchmark

Q-Score

45/ 100

Quality against peers; 50 is the peer median.

Growth47
Risk62
Performance37
Valuation44
Profitability52
Leverage54
Sentiment—
Every score and metric

News sentiment

Open News

Latest results · FY 2025

Revenue$980.6M+3.3%
Net income$53.8M-16.0%
Net margin5.5%-1.3 pts
Historical fundamentals

Revenue exposure

47%of revenue from outside the US
United States53%
Rest of Europe14%
Germany12%
Largest customer12%
Regions, segments, customers and suppliers

Valuation

NOVTIndustryP/E88.0631.92P/S4.304.83EV/EBITDA33.9922.35P/B2.883.93PEG—0.55
Dividend yield0.00%
Every valuation metric

Earnings

Nov 9next report, after the close
EPS estimate$0.97
Beats (last 4 quarters)—
Average surprise—
EPS revisions (30d)—
Every quarter against its estimate